Blog - New Street

Biotech IR Blog by Our CEO and Founder, Laurence Watts.

February 5, 2025

Should Biotechs Hold Quarterly Earnings Calls (and What Happens if You “Set Precedent”)?

Cutting to the chase, the answer to the question posed is generally, “no,” but there are exceptions. So, let me spend the rest of this essay explaining why quarterly earnings calls are generally a bad idea for biotechs, and when those exceptions might occur. The key word and clue is embedded within the question: earnings. […]

January 29, 2025

How Many Healthcare Investor Conferences Should a Biotech Attend Each Year?

Going to healthcare conferences takes a lot of time and money. Typically, both a biotech’s CEO and CFO are in attendance for one or more days. Then there’s the amount of downtime associated with traveling to and from each conference (which is more for West Coast biotechs, given most healthcare investor conferences are on the […]

December 30, 2024

What Did U.S. Biotechs Learn from Silicon Valley Bank’s Collapse in 2023?

On Friday, March 10, 2023 – less than two years ago at the time of writing – Silicon Valley Bank (SVB) failed after a run on its deposit base. At the time it was the second largest bank failure in U.S history with approximately $209 billion of assets when it went under. It would become […]

December 23, 2024

What’s The Difference Between Investor Relations and Public Relations for Biotechs?

A lot of first-time biotech CEOs and CFOs confuse and conflate investor relations with public relations. So, I thought it would be good to address the issue, and then talk a little about why such confusion exists. Put simply, the difference between investor relations and public relations is their target audience and the relationships their […]

December 16, 2024

Should I Bother Going to The J.P. Morgan Healthcare Investor Conference if I’m a Small/Medium Sized Biotech?

Forst of all, let’s be honest: you want me to say “No”, right? The J.P. Morgan Healthcare Investor Conference is the week most people love to hate. Not only is it a super-spreader event for COVID, HMPV, RSV, flu and goodness knows what else, it’s usually marred by cold and rainy weather, with more than […]

December 9, 2024

Avoid Kitchen Sink Investor Announcements

I can count more times than I care to mention the number of times I have had to caution a management team not to “put it all in one release.” In fact, a long time ago I had a client who’s CEO was convinced that the more news that was packed into a single press […]

December 2, 2024

Dates to Avoid When Making Important Investor Announcements

Recently, I was editing a clinical data release for a client of mine. The data looked great. It was a very positive release. But my stomach sank when I realized the date the prospective announcement was scheduled to go out: September 11. Now, the timing of the release clearly had no bearing on how awesome […]